OCGN Stock Forecast 2025
The OCGN stock forecast for 2025 is a topic of significant interest for investors and analysts. OCGN, or Ocugen, Inc., is a clinical-stage biopharmaceutical company focused on developing gene therapies for ocular diseases. The company’s lead product candidate, OCU400, is a gene therapy for the treatment of retinitis pigmentosa, a rare genetic eye disease that leads to vision loss.
